Amgen (AMGN) Assets (2009 - 2026)
Amgen (AMGN) posted quarterly Assets of $92.5 billion for Q1 2026, up 3.51% year-over-year from $89.4 billion in Q1 2025, and up 2.12% quarter-over-quarter from $90.6 billion in Q4 2025.
Amgen (AMGN) Assets (2009 - 2026) Analysis & Trends
Amgen's Assets history runs 18 years deep, the most recent figure standing at $92.5 billion for Q1 2026.
- In Q1 2026, Assets rose 3.51% year-over-year to $92.5 billion; the TTM figure through Mar 2026 stood at $92.5 billion (up 3.51% YoY), while the FY2025 annual figure was $90.6 billion, down 1.36% from the prior year.
- Assets for Q1 2026 stood at $92.5 billion, up from $90.6 billion in the prior quarter.
- The five-year high for Assets was $97.2 billion in Q4 2023, with the low at $59.2 billion in Q1 2022.
- The 5-year median for Assets is $90.3 billion (2023), against an average of $84.2 billion.
- The sharpest annual moves came in 2023 and 2024: Assets surged 52.24% in 2023, then declined 5.47% in 2024.
- Amgen's Assets stood at $65.1 billion in 2022, then jumped by 49.19% to $97.2 billion in 2023, then dropped by 5.47% to $91.8 billion in 2024, then declined by 1.36% to $90.6 billion in 2025, then grew by 2.12% to $92.5 billion in 2026.
- Business Quant data shows AMGN's Assets at $92.5 billion in Q1 2026, $90.6 billion in Q4 2025, and $90.1 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 82.83 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 150.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 95.64 Bn |
| Mar 31, 2026 | 92.50 Bn |
| Dec 31, 2025 | 90.59 Bn |
| Sep 30, 2025 | 90.14 Bn |
| Jun 30, 2025 | 87.90 Bn |
| Mar 31, 2025 | 89.37 Bn |
| Dec 31, 2024 | 91.84 Bn |
| Sep 30, 2024 | 90.88 Bn |
| Jun 30, 2024 | 90.91 Bn |
| Mar 31, 2024 | 92.98 Bn |
| Dec 31, 2023 | 97.15 Bn |
| Sep 30, 2023 | 90.53 Bn |
| Jun 30, 2023 | 90.27 Bn |
| Mar 31, 2023 | 88.72 Bn |
| Dec 31, 2022 | 65.12 Bn |
| Sep 30, 2022 | 63.70 Bn |
| Jun 30, 2022 | 59.29 Bn |
| Mar 31, 2022 | 59.20 Bn |
| Dec 31, 2021 | 61.17 Bn |
| Sep 30, 2021 | 64.99 Bn |